Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
How Condensate Coronas Transfer RNA Cargo
2026-11-04
The study identifies rare synthetic nanoparticle–condensate hybrids that carry proteins and RNA between cells, distinguishes them from extracellular vesicles, and links endosomal cargo release to condensate–membrane recognition. Its strongest contribution is mechanistic: convergent imaging, proteomic, transcriptomic, and reporter evidence supports a route for privileged intracellular access, while rarity, ensemble measurements, and model-specific particle architecture limit broad extrapolation.
How Condensate Coronas Enable RNA Transfer
2026-11-04
A Nature Materials study describes rare nanoparticle–cell hybrids whose condensate-like coronas carry intact proteins and RNA between cells. The evidence supports a mechanistic model involving selective export, endosomal detachment and intracellular redistribution, while leaving quantitative transfer efficiency, generality across cargoes and applicability beyond the tested particle–cell systems unresolved.
How Condensate Coronas Enable RNA Transfer
2026-11-03
A mechanistic analysis of how rare nanoparticle–condensate complexes acquire, protect and release functional proteins and RNAs, with attention to the strength and limits of the supporting evidence.
How Condensate Coronas Move Biomolecules Between Cells
2026-11-03
A recent study describes a rare form of nanoparticle–cell interaction in which an internalized particle acquires a cell-derived biomolecular condensate corona, is re-exported, and later releases proteins and RNA inside recipient cells. The findings broaden current models of extracellular vesicle-independent communication while leaving important questions about event frequency, molecular selectivity and applicability beyond the tested cellular systems.
Rare-Event Nanoparticles and Biomolecular Transfer
2026-11-02
A published study describes a rare class of nanoparticle–condensate hybrids that can carry proteins and RNA between cells. Its strongest evidence concerns particle composition and intracellular trafficking; the extent, selectivity and generality of functional transfer remain unresolved.
How Condensate Coronas Transfer Biomolecules
2026-11-02
A literature-focused analysis of how rare nanoparticle–condensate complexes acquire cellular biomolecules, move between cells, and gain intracellular access. The study distinguishes these complexes from extracellular vesicles while highlighting important limits around rarity, ensemble measurements, model specificity, and transferability.
How Condensate Coronas Move Biomolecules Between Cells
2026-11-01
A recent study describes rare nanoparticle–cell hybrids that acquire condensate-like biological coronas, are re-exported, and deliver intact proteins and RNAs to recipient-cell compartments. The strongest evidence supports a mechanistic model involving condensate detachment from the particle inside endosomal compartments, while the study leaves open how frequently the process occurs and how broadly it applies across nanoparticle designs, cell types, and cargoes.
How Condensate Coronas Transfer Biomolecular Cargo
2026-10-31
A Nature Materials study describes rare nanoparticle–cell condensate hybrids that acquire proteins and long RNAs, are re-exported, and deliver cargo to recipient-cell compartments. The findings clarify a possible mechanism for intracellular access while leaving major questions about prevalence, generality, and translational relevance.
What Multiplex CRISPR Evidence Really Shows
2026-10-30
Multiplex CRISPR can expose gene interactions and generate complex genomic changes, but added targets also increase DNA-damage and off-target risks. The strongest evidence supports a versatile research platform; it does not by itself establish therapeutic selectivity, delivery, or performance in any particular cell product.
Condensate Coronas as a Route for RNA Transfer
2026-10-30
A source-grounded analysis of how rare nanoparticle–condensate complexes acquire, protect and redistribute cellular proteins and RNAs, and what the evidence does—and does not—establish about intercellular biomolecule transfer.
How Condensate Coronas Alter Nanoparticle Transfer
2026-10-29
A recent study describes a rare class of nanoparticle–condensate hybrids that transport proteins and long RNAs between cells. Its strongest evidence supports a distinct intracellular trafficking route, while the frequency, cargo heterogeneity and generality of the mechanism remain unresolved.
When Context Changes a Juvenile Hormone Result
2026-10-29
A locust study shows why the same juvenile hormone analog can mean different things depending on developmental stage, upstream hormone synthesis, molecular readout, and comparator. The evidence supports a context-specific model of juvenile hormone–dependent reproduction, not a universal claim about analog activity.
How Quinupristin Halts Bacterial Translation
2026-10-28
Quinupristin (mesylate) is a streptogramin B antibiotic whose documented significance depends on how ribosome-level inhibition is connected to population-level bacterial measurements. This article distinguishes the molecular mechanism, combination-dependent interpretation, reported infection-model findings, and the limits of catalog-based evidence.
How Condensate Coronas Transfer RNA
2026-10-28
A literature-focused analysis of how rare nanoparticle–condensate complexes acquire cell-derived biomolecules, escape endosomal processing and transfer functional RNA and proteins, while distinguishing demonstrated mechanisms from broader delivery implications.
Condensate Coronas and Nanoparticle Cargo Transfer
2026-10-27
A 2026 Nature Materials study describes a rare form of nanoparticle–cell interaction in which synthetic particles acquire cell-derived biomolecular condensates, are re-exported, and transfer proteins and RNA to recipient cells. The evidence distinguishes these complexes from conventional extracellular vesicles and links their intracellular behavior to condensate–endosome interactions. The findings establish a mechanistic framework for studying privileged intracellular access, while leaving important questions about frequency, cargo specificity, biological consequences, and generalizability.